Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1965 1
1976 1
1979 1
1981 3
1982 2
1983 1
1984 2
1985 3
1987 2
1988 8
1989 5
1990 1
1991 2
2001 3
2002 5
2003 4
2004 6
2005 5
2006 6
2007 3
2008 3
2009 8
2010 9
2011 3
2012 12
2013 10
2014 6
2015 6
2016 11
2017 6
2018 13
2019 6
2020 10
2021 12
2022 19
2023 8
2024 6

Text availability

Article attribute

Article type

Publication date

Search Results

190 results

Results by year

Filters applied: . Clear all
Page 1
Migraine: disease characterisation, biomarkers, and precision medicine.
Ashina M, Terwindt GM, Al-Karagholi MA, de Boer I, Lee MJ, Hay DL, Schulte LH, Hadjikhani N, Sinclair AJ, Ashina H, Schwedt TJ, Goadsby PJ. Ashina M, et al. Among authors: hay dl. Lancet. 2021 Apr 17;397(10283):1496-1504. doi: 10.1016/S0140-6736(20)32162-0. Epub 2021 Mar 25. Lancet. 2021. PMID: 33773610 Review.
Amylin.
Hay DL. Hay DL. Headache. 2017 May;57 Suppl 2:89-96. doi: 10.1111/head.13077. Headache. 2017. PMID: 28485843 Review.
The Concise Guide to PHARMACOLOGY 2023/24: G protein-coupled receptors.
Alexander SPH, Christopoulos A, Davenport AP, Kelly E, Mathie AA, Peters JA, Veale EL, Armstrong JF, Faccenda E, Harding SD, Davies JA, Abbracchio MP, Abraham G, Agoulnik A, Alexander W, Al-Hosaini K, Bäck M, Baker JG, Barnes NM, Bathgate R, Beaulieu JM, Beck-Sickinger AG, Behrens M, Bernstein KE, Bettler B, Birdsall NJM, Blaho V, Boulay F, Bousquet C, Bräuner-Osborne H, Burnstock G, Caló G, Castaño JP, Catt KJ, Ceruti S, Chazot P, Chiang N, Chini B, Chun J, Cianciulli A, Civelli O, Clapp LH, Couture R, Cox HM, Csaba Z, Dahlgren C, Dent G, Douglas SD, Dournaud P, Eguchi S, Escher E, Filardo EJ, Fong T, Fumagalli M, Gainetdinov RR, Garelja ML, de Gasparo M, Gerard C, Gershengorn M, Gobeil F, Goodfriend TL, Goudet C, Grätz L, Gregory KJ, Gundlach AL, Hamann J, Hanson J, Hauger RL, Hay DL, Heinemann A, Herr D, Hollenberg MD, Holliday ND, Horiuchi M, Hoyer D, Hunyady L, Husain A, IJzerman AP, Inagami T, Jacobson KA, Jensen RT, Jockers R, Jonnalagadda D, Karnik S, Kaupmann K, Kemp J, Kennedy C, Kihara Y, Kitazawa T, Kozielewicz P, Kreienkamp HJ, Kukkonen JP, Langenhan T, Larhammar D, Leach K, Lecca D, Lee JD, Leeman SE, Leprince J, Li XX, Lolait SJ, Lupp A, Macrae R, Maguire J, … See abstract for full author list ➔ Alexander SPH, et al. Among authors: hay dl. Br J Pharmacol. 2023 Oct;180 Suppl 2:S23-S144. doi: 10.1111/bph.16177. Br J Pharmacol. 2023. PMID: 38123151 Free article.
Atogepant (Qulipta®) for migraine prevention.
Hay DL, Walker CS, Harris PWR. Hay DL, et al. Trends Pharmacol Sci. 2022 Aug;43(8):701-702. doi: 10.1016/j.tips.2022.03.013. Epub 2022 Apr 22. Trends Pharmacol Sci. 2022. PMID: 35469689 No abstract available.
New Insights into the Regulation of CGRP-Family Receptors.
Gingell JJ, Hendrikse ER, Hay DL. Gingell JJ, et al. Among authors: hay dl. Trends Pharmacol Sci. 2019 Jan;40(1):71-83. doi: 10.1016/j.tips.2018.11.005. Epub 2018 Dec 4. Trends Pharmacol Sci. 2019. PMID: 30527443 Review.
190 results